IMCC
Price
$2.32
Change
-$0.12 (-4.92%)
Updated
Aug 29 closing price
Capitalization
12.8M
KAYS
Price
$0.02
Change
+$0.01 (+100.00%)
Updated
Aug 29 closing price
Capitalization
1.03M
Interact to see
Advertisement

IMCC vs KAYS

Header iconIMCC vs KAYS Comparison
Open Charts IMCC vs KAYSBanner chart's image
IM Cannabis
Price$2.32
Change-$0.12 (-4.92%)
Volume$39.86K
Capitalization12.8M
Kaya Holdings
Price$0.02
Change+$0.01 (+100.00%)
Volume$27.36K
Capitalization1.03M
IMCC vs KAYS Comparison Chart in %
Loading...
IMCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KAYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMCC vs. KAYS commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMCC is a Buy and KAYS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (IMCC: $2.32 vs. KAYS: $0.02)
Brand notoriety: IMCC and KAYS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: IMCC: 71% vs. KAYS: 103%
Market capitalization -- IMCC: $12.8M vs. KAYS: $1.03M
IMCC [@Pharmaceuticals: Generic] is valued at $12.8M. KAYS’s [@Pharmaceuticals: Generic] market capitalization is $1.03M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMCC’s FA Score shows that 0 FA rating(s) are green whileKAYS’s FA Score has 1 green FA rating(s).

  • IMCC’s FA Score: 0 green, 5 red.
  • KAYS’s FA Score: 1 green, 4 red.
According to our system of comparison, KAYS is a better buy in the long-term than IMCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMCC’s TA Score shows that 3 TA indicator(s) are bullish while KAYS’s TA Score has 5 bullish TA indicator(s).

  • IMCC’s TA Score: 3 bullish, 5 bearish.
  • KAYS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, KAYS is a better buy in the short-term than IMCC.

Price Growth

IMCC (@Pharmaceuticals: Generic) experienced а +0.43% price change this week, while KAYS (@Pharmaceuticals: Generic) price change was +74.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.55%. For the same industry, the average monthly price growth was +67.47%, and the average quarterly price growth was +80.21%.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.55% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMCC($12.8M) has a higher market cap than KAYS($1.04M). IMCC YTD gains are higher at: -0.476 vs. KAYS (-11.071). IMCC has higher annual earnings (EBITDA): 3.96M vs. KAYS (-1.68M). IMCC has more cash in the bank: 794K vs. KAYS (50.7K). KAYS has less debt than IMCC: KAYS (9.17M) vs IMCC (15.6M). IMCC has higher revenues than KAYS: IMCC (52.4M) vs KAYS (14.2K).
IMCCKAYSIMCC / KAYS
Capitalization12.8M1.04M1,237%
EBITDA3.96M-1.68M-236%
Gain YTD-0.476-11.0714%
P/E RatioN/A3.30-
Revenue52.4M14.2K369,014%
Total Cash794K50.7K1,566%
Total Debt15.6M9.17M170%
FUNDAMENTALS RATINGS
KAYS: Fundamental Ratings
KAYS
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMCCKAYS
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
72%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 11 days ago
67%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
IMCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KAYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLGL22.790.89
+4.06%
Sol-Gel Technologies Ltd
ATR139.270.38
+0.27%
AptarGroup
CCB114.500.20
+0.17%
Coastal Financial Corp
ONBPP25.18-0.09
-0.36%
Old National Bancorp
BBCP6.96-0.11
-1.56%
Concrete Pumping Holdings

IMCC and

Correlation & Price change

A.I.dvisor tells us that IMCC and CRON have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMCC and CRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCC
1D Price
Change %
IMCC100%
-4.92%
CRON - IMCC
25%
Poorly correlated
N/A
SHIEF - IMCC
25%
Poorly correlated
N/A
DVAX - IMCC
23%
Poorly correlated
-1.46%
SCYX - IMCC
22%
Poorly correlated
-2.17%
SNDL - IMCC
22%
Poorly correlated
-0.37%
More

KAYS and

Correlation & Price change

A.I.dvisor tells us that KAYS and KMDA have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KAYS and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAYS
1D Price
Change %
KAYS100%
+90.08%
KMDA - KAYS
21%
Poorly correlated
-1.42%
UPC - KAYS
8%
Poorly correlated
-0.10%
SHIEF - KAYS
4%
Poorly correlated
N/A
TRUFF - KAYS
4%
Poorly correlated
-4.06%
IMCC - KAYS
3%
Poorly correlated
-4.92%
More